vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and PROSPERITY BANCSHARES INC (PB). Click either name above to swap in a different company.
PROSPERITY BANCSHARES INC is the larger business by last-quarter revenue ($275.0M vs $151.7M, roughly 1.8× Nutex Health, Inc.). PROSPERITY BANCSHARES INC runs the higher net margin — 50.9% vs 7.8%, a 43.1% gap on every dollar of revenue. On growth, PROSPERITY BANCSHARES INC posted the faster year-over-year revenue change (2.7% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $68.5M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 7.4%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
NUTX vs PB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $275.0M |
| Net Profit | $11.8M | $139.9M |
| Gross Margin | 30.4% | — |
| Operating Margin | 20.4% | 65.1% |
| Net Margin | 7.8% | 50.9% |
| Revenue YoY | -41.1% | 2.7% |
| Net Profit YoY | -80.8% | 7.6% |
| EPS (diluted) | $2.34 | $1.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $275.0M | ||
| Q3 25 | $267.8M | $273.4M | ||
| Q2 25 | $244.0M | $267.7M | ||
| Q1 25 | $211.8M | $265.4M | ||
| Q4 24 | $257.6M | $267.8M | ||
| Q3 24 | $78.8M | $261.7M | ||
| Q2 24 | $76.1M | $258.8M | ||
| Q1 24 | $67.5M | $238.2M |
| Q4 25 | $11.8M | $139.9M | ||
| Q3 25 | $55.4M | $137.6M | ||
| Q2 25 | $-17.7M | $135.2M | ||
| Q1 25 | $21.2M | $130.2M | ||
| Q4 24 | $61.6M | $130.1M | ||
| Q3 24 | $-8.8M | $127.3M | ||
| Q2 24 | $-364.0K | $111.6M | ||
| Q1 24 | $-364.0K | $110.4M |
| Q4 25 | 30.4% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 55.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 29.7% | — | ||
| Q1 24 | 15.1% | — |
| Q4 25 | 20.4% | 65.1% | ||
| Q3 25 | 48.7% | 64.4% | ||
| Q2 25 | 13.8% | 64.3% | ||
| Q1 25 | 38.1% | 62.7% | ||
| Q4 24 | 44.4% | 62.0% | ||
| Q3 24 | 12.3% | 62.1% | ||
| Q2 24 | 7.0% | 55.2% | ||
| Q1 24 | 2.1% | 59.3% |
| Q4 25 | 7.8% | 50.9% | ||
| Q3 25 | 20.7% | 50.3% | ||
| Q2 25 | -7.3% | 50.5% | ||
| Q1 25 | 10.0% | 49.1% | ||
| Q4 24 | 23.9% | 48.6% | ||
| Q3 24 | -11.2% | 48.6% | ||
| Q2 24 | -0.5% | 43.1% | ||
| Q1 24 | -0.5% | 46.3% |
| Q4 25 | $2.34 | $1.48 | ||
| Q3 25 | $7.76 | $1.45 | ||
| Q2 25 | $-2.95 | $1.42 | ||
| Q1 25 | $3.33 | $1.37 | ||
| Q4 24 | $11.56 | $1.36 | ||
| Q3 24 | $-1.72 | $1.34 | ||
| Q2 24 | $-0.07 | $1.17 | ||
| Q1 24 | $-0.08 | $1.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | $7.6B |
| Total Assets | $918.5M | $38.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | — | ||
| Q3 25 | $166.0M | — | ||
| Q2 25 | $96.7M | — | ||
| Q1 25 | $84.7M | — | ||
| Q4 24 | $40.6M | — | ||
| Q3 24 | $46.9M | — | ||
| Q2 24 | $40.8M | — | ||
| Q1 24 | $30.0M | — |
| Q4 25 | $329.4M | $7.6B | ||
| Q3 25 | $317.2M | $7.7B | ||
| Q2 25 | $235.3M | $7.6B | ||
| Q1 25 | $176.9M | $7.5B | ||
| Q4 24 | $132.4M | $7.4B | ||
| Q3 24 | $60.4M | $7.4B | ||
| Q2 24 | $62.7M | $7.3B | ||
| Q1 24 | $63.0M | $7.1B |
| Q4 25 | $918.5M | $38.5B | ||
| Q3 25 | $964.5M | $38.3B | ||
| Q2 25 | $841.0M | $38.4B | ||
| Q1 25 | $761.9M | $38.8B | ||
| Q4 24 | $655.3M | $39.6B | ||
| Q3 24 | $438.5M | $40.1B | ||
| Q2 24 | $422.4M | $39.8B | ||
| Q1 24 | $404.3M | $38.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $78.3M |
| Free Cash FlowOCF − Capex | $69.0M | $68.5M |
| FCF MarginFCF / Revenue | 45.5% | 24.9% |
| Capex IntensityCapex / Revenue | 0.9% | 3.6% |
| Cash ConversionOCF / Net Profit | 5.95× | 0.56× |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $517.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $78.3M | ||
| Q3 25 | $99.5M | $194.8M | ||
| Q2 25 | $27.3M | $98.2M | ||
| Q1 25 | $51.0M | $178.2M | ||
| Q4 24 | $54.0K | $-205.8M | ||
| Q3 24 | $6.8M | $274.6M | ||
| Q2 24 | $13.3M | $216.5M | ||
| Q1 24 | $3.1M | $187.4M |
| Q4 25 | $69.0M | $68.5M | ||
| Q3 25 | $99.2M | $185.7M | ||
| Q2 25 | $26.5M | $91.8M | ||
| Q1 25 | $50.9M | $171.1M | ||
| Q4 24 | $-341.0K | $-210.7M | ||
| Q3 24 | $6.2M | $270.2M | ||
| Q2 24 | $12.7M | $211.8M | ||
| Q1 24 | $2.3M | $180.2M |
| Q4 25 | 45.5% | 24.9% | ||
| Q3 25 | 37.0% | 67.9% | ||
| Q2 25 | 10.9% | 34.3% | ||
| Q1 25 | 24.0% | 64.5% | ||
| Q4 24 | -0.1% | -78.7% | ||
| Q3 24 | 7.8% | 103.3% | ||
| Q2 24 | 16.7% | 81.8% | ||
| Q1 24 | 3.4% | 75.6% |
| Q4 25 | 0.9% | 3.6% | ||
| Q3 25 | 0.1% | 3.3% | ||
| Q2 25 | 0.3% | 2.4% | ||
| Q1 25 | 0.0% | 2.7% | ||
| Q4 24 | 0.2% | 1.8% | ||
| Q3 24 | 0.8% | 1.7% | ||
| Q2 24 | 0.7% | 1.8% | ||
| Q1 24 | 1.1% | 3.0% |
| Q4 25 | 5.95× | 0.56× | ||
| Q3 25 | 1.80× | 1.42× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | 2.40× | 1.37× | ||
| Q4 24 | 0.00× | -1.58× | ||
| Q3 24 | — | 2.16× | ||
| Q2 24 | — | 1.94× | ||
| Q1 24 | — | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
PB
Segment breakdown not available.
